NEW YORK, March 7, 2017 /PRNewswire/ --
The cannabis industry is one of the fastest growing industries, as more states in the U.S. have legalized cannabis for either medical or recreational use. According to a new report published by New Frontier Data, total cannabis market sales are expected to exceed $24 billion by 2025. Medical cannabis sales are projected to grow to $13.3 billion in 2020. While adult recreational sales are expected to grow from $2.6 billion in 2016 to $11.2 billion by 2020. Rapid adoption of cannabis by consumers and surging pace of cannabis legalization have attributed to the expanding industry. CURE Pharmaceutical Holding Corp. (OTC: CURR), Aurora Cannabis Inc. (OTC: ACBFF), MassRoots Inc. (OTC: MSRT), American Cannabis Company Inc. (OTC: AMMJ), General Cannabis Corporation (OTC: CANN)
Cannabis for medical use is now legal in 28 U.S. states, while 8 states have legalized recreational cannabis. On November 8, 2016, California, a state with 38 million U.S. citizens, had passed California Proposition 64 by a vote of 57.13% for and 42.87% against, allowing individuals in California to use and grow cannabis for personal use. Maine, Massachusetts, and Nevada also legalized recreational cannabis in 2016. Increased supports for cannabis may drive more states to implement legalization in the future. According to the data from National pollster Gallup, support for nationwide legalization of cannabis is 60% in 2016 poll, up from 25% in 1995.
CURE Pharmaceutical Holding Corp. (OTCQB: CURR), is a drug delivery technology company serving the pharmaceutical, biotech, veterinarian, nutraceutical and medical foods markets. The company announced yesterday after the market close that, "a research collaboration with CannaKids in order to develop and research the delivery of various forms and components of cannabinoid molecules for both human and animal therapeutic use via CURE's patented drug delivery technology. Multiple human and animal studies have shown that endocannabinoids may play a key role in metabolic processes, lipolysis, pain, gastrointestinal and cancer."
"This is a logical step for CURE, as the demand for cannabinoid therapeutics has already gained momentum, we have created an entire division of the company dedicated to the discovery and development of clinically proven and New Chemical Entities (NCEs), cannabinoid drug molecules integrated into our proprietary CureFilm™ and other delivery technologies," said Rob Davidson, CEO of CURE Pharmaceutical. "Some of these drugs will be repurposed for new indications, delivered through alternate routes, designed as prodrugs, combined with other drugs and through the use of our proprietary delivery technologies titer the accurate dosage for optimal effectiveness."
CURE Pharmaceutical is taking a leadership role in optimizing plant base cannabinoids, by vertically integrating drug discovery, proprietary extraction technology, genetic-specific cannabinoids research, and drug development. "CURE's strategy is to bring new cannabinoid molecules to the market through the FDA regulatory approval process while utilizing its proprietary delivery technologies to increase efficacy as well as widening the overall therapeutic index," said Dr. Ed Maliski, Chief Scientific Officer, CURE Pharmaceutical.
Aurora Cannabis Inc. (OTCQB: ACBFF) wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations. The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as 'Aurora Sky', at the Edmonton International Airport. The Aurora Sky project has secured advanced technology from the most renowned design and construction suppliers in the Netherlands. The company had unveiled the second generation of its popular mobile application, incorporating a number of enhanced features to provide a significantly upgraded user experience to new and existing clients of the Company. Coupled with Aurora's industry leading same-day and next-day delivery services, the app further expands the Company's e-commerce strategy, a key differentiator in the legal cannabis market.
MassRoots Inc. (OTCQB: MSRT) is one of the largest technology platforms for the regulated cannabis industry. The Company's mobile apps enable consumers to make medical cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots is not associated with the production or sale of cannabis, rather the company is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over 900,000 registered users.
American Cannabis Company Inc. (OTCQB: AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The Satchel™, SoHum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. We also design and provide other industry specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, "the art and science of agriculture in soil."
General Cannabis Corporation (OTCQB: CANN) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. The company is a partner to the cultivation, production and retail side of the cannabis business. They do this through a combination of strong operating divisions such as real estate, consulting, security, financing and the distribution of important infrastructure products to grow facilities and dispensaries. As a synergistic holding company, their subsidiaries are able to leverage the strengths of each other, as well as a larger balance sheet.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. FinancialBuzz.com only regurgitates financial or corporate news through our unique financial newswire and media platform. FinancialBuzz.com has been compensated a total of eight thousand dollars for financial news dissemination and pr services by a third party non affiliate for cure pharmaceutical holding corp. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com
For further information: Media Contact: [email protected] +1-877-601-1879 Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com
Advertisement
The cannabis industry is one of the fastest growing industries, as more states in the U.S. have legalized cannabis for either medical or recreational use. According to a new report published by New Frontier Data, total cannabis market sales are expected to exceed $24 billion by 2025. Medical cannabis sales are projected to grow to $13.3 billion in 2020. While adult recreational sales are expected to grow from $2.6 billion in 2016 to $11.2 billion by 2020. Rapid adoption of cannabis by consumers and surging pace of cannabis legalization have attributed to the expanding industry. CURE Pharmaceutical Holding Corp. (OTC: CURR), Aurora Cannabis Inc. (OTC: ACBFF), MassRoots Inc. (OTC: MSRT), American Cannabis Company Inc. (OTC: AMMJ), General Cannabis Corporation (OTC: CANN)
Advertisement
Cannabis for medical use is now legal in 28 U.S. states, while 8 states have legalized recreational cannabis. On November 8, 2016, California, a state with 38 million U.S. citizens, had passed California Proposition 64 by a vote of 57.13% for and 42.87% against, allowing individuals in California to use and grow cannabis for personal use. Maine, Massachusetts, and Nevada also legalized recreational cannabis in 2016. Increased supports for cannabis may drive more states to implement legalization in the future. According to the data from National pollster Gallup, support for nationwide legalization of cannabis is 60% in 2016 poll, up from 25% in 1995.
CURE Pharmaceutical Holding Corp. (OTCQB: CURR), is a drug delivery technology company serving the pharmaceutical, biotech, veterinarian, nutraceutical and medical foods markets. The company announced yesterday after the market close that, "a research collaboration with CannaKids in order to develop and research the delivery of various forms and components of cannabinoid molecules for both human and animal therapeutic use via CURE's patented drug delivery technology. Multiple human and animal studies have shown that endocannabinoids may play a key role in metabolic processes, lipolysis, pain, gastrointestinal and cancer."
"This is a logical step for CURE, as the demand for cannabinoid therapeutics has already gained momentum, we have created an entire division of the company dedicated to the discovery and development of clinically proven and New Chemical Entities (NCEs), cannabinoid drug molecules integrated into our proprietary CureFilm™ and other delivery technologies," said Rob Davidson, CEO of CURE Pharmaceutical. "Some of these drugs will be repurposed for new indications, delivered through alternate routes, designed as prodrugs, combined with other drugs and through the use of our proprietary delivery technologies titer the accurate dosage for optimal effectiveness."
CURE Pharmaceutical is taking a leadership role in optimizing plant base cannabinoids, by vertically integrating drug discovery, proprietary extraction technology, genetic-specific cannabinoids research, and drug development. "CURE's strategy is to bring new cannabinoid molecules to the market through the FDA regulatory approval process while utilizing its proprietary delivery technologies to increase efficacy as well as widening the overall therapeutic index," said Dr. Ed Maliski, Chief Scientific Officer, CURE Pharmaceutical.
Aurora Cannabis Inc. (OTCQB: ACBFF) wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations. The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as 'Aurora Sky', at the Edmonton International Airport. The Aurora Sky project has secured advanced technology from the most renowned design and construction suppliers in the Netherlands. The company had unveiled the second generation of its popular mobile application, incorporating a number of enhanced features to provide a significantly upgraded user experience to new and existing clients of the Company. Coupled with Aurora's industry leading same-day and next-day delivery services, the app further expands the Company's e-commerce strategy, a key differentiator in the legal cannabis market.
MassRoots Inc. (OTCQB: MSRT) is one of the largest technology platforms for the regulated cannabis industry. The Company's mobile apps enable consumers to make medical cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots is not associated with the production or sale of cannabis, rather the company is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over 900,000 registered users.
American Cannabis Company Inc. (OTCQB: AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The Satchel™, SoHum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. We also design and provide other industry specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, "the art and science of agriculture in soil."
General Cannabis Corporation (OTCQB: CANN) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. The company is a partner to the cultivation, production and retail side of the cannabis business. They do this through a combination of strong operating divisions such as real estate, consulting, security, financing and the distribution of important infrastructure products to grow facilities and dispensaries. As a synergistic holding company, their subsidiaries are able to leverage the strengths of each other, as well as a larger balance sheet.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. FinancialBuzz.com only regurgitates financial or corporate news through our unique financial newswire and media platform. FinancialBuzz.com has been compensated a total of eight thousand dollars for financial news dissemination and pr services by a third party non affiliate for cure pharmaceutical holding corp. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com
For further information: Media Contact: [email protected] +1-877-601-1879 Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com
